Search

everythinglearnresearchcommunity

for

Search:↓

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

AMP-303 safely increases hair growth in men with hair loss.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Divalproex sodium can sometimes worsen behavior in some patients.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Finasteride may help improve certain brain function issues linked to dopamine.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.